Cancer epigenetics (Q35551103)

8 August 2017

1 reference

title

Cancer epigenetics (English)

1 reference

8 August 2017

1 reference

Richard L Momparler

1

1 reference

PubMed ID

14528271

8 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

8 August 2017

1 reference

8 August 2017

22

1 reference

8 August 2017

6479-6483

1 reference

8 August 2017

42

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1206774

8 August 2017

0 references

cites work

Epigenetic cancer therapies: DNA methyltransferase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

21 January 2018

DNA replication fidelity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

Histone deacetylases and cancer: causes and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

DNA methylation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

DNA methylation is a reversible biological signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Mechanisms underlying epigenetically mediated gene silencing in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Antineoplastic action of 5-aza-2'-deoxycytidine and phenylbutyrate on human lung carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Antineoplastic action of 5-aza-2'-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Demethylation by 5-aza-2'-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Interaction of 5-aza-2'-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3sigma, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Aging, DNA methylation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Translating the Histone Code

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

The fundamental role of epigenetic events in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Cancer epigenetics comes of age

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Results of decitabine therapy in the accelerated and blastic phases of chronic myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Mutation and cancer: statistical study of retinoblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Chromatin modification and epigenetic reprogramming in mammalian development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Methylation and silencing of the Thrombospondin-1 promoter in human cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Potential of 5-aza-2'-deoxycytidine (Decitabine) a potent inhibitor of DNA methylation for therapy of advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Clinical trial on 5-aza-2'-deoxycytidine in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Epigenetic gene silencing in cancer initiation and progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Synergistic antineoplastic action of DNA methylation inhibitor 5-AZA-2'-deoxycytidine and histone deacetylase inhibitor depsipeptide on human breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Phase I study on 5-aza-2′-deoxycytidine in children with acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

DNA methylation analysis: a powerful new tool for lung cancer diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

DNMT1 is a component of a multiprotein DNA replication complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206774

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1206774

1 reference

PubMed ID

14528271

Dimensions Publication ID

8 August 2017

0 references

1 reference

PubMed ID

14528271